HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

Abstract
Congenital disorders of glycosylation (CDGs) are a rapidly enlarging group of inherited diseases with abnormal N-glycosylation of glycoconjugates. Most patients have CDG-Ia, which is due to a phosphomannomutase (PMM) deficiency. In this article, we report that a significant portion (9 of 54) of patients with CDG-Ia had a rather high residual PMM activity in fibroblasts included in the normal range (means of the controls +/- 2 SD) and amounting to 35%-70% of the mean control value. The clinical diagnosis of CDG-Ia was made difficult by the fact that most (6 of 9) of these patients belong to a subgroup characterized by a phenotype that is milder than classical CDG-Ia. These patients lack some of the symptoms that are suggestive for the diagnosis, such as inverted nipples and abnormal fat deposition, and, as a mean, had higher residual PMM activities in fibroblasts (2.05+/-0.61 mU/mg protein, n=9; vs. controls 5.34+/-1.74 mU/mg protein, n=22), compared with patients with moderate (1.32+/-0.86 mU/mg protein, n=18) or severe (0.63+/-0.56 mU/mg protein, n=27, P<.001) cases. Yet they all showed mild mental retardation, hypotonia, cerebellar hypoplasia, and strabismus. All of them had an abnormal serum transferrin pattern and a significantly reduced PMM activity in leukocytes. Six of the nine patients with mild presentations were compound heterozygotes for the C241S mutation, which is known to reduce PMM activity by only approximately 2-fold. Our results indicate that intermediate PMM values in fibroblasts may mask the diagnosis of CDG-Ia, which is better accomplished by measurement of PMM activity in leukocytes and mutation search in the PMM2 gene. They also indicate that there is some degree of correlation between the residual activity in fibroblasts and the clinical phenotype.
AuthorsS Grünewald, E Schollen, E Van Schaftingen, J Jaeken, G Matthijs
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 68 Issue 2 Pg. 347-54 (Feb 2001) ISSN: 0002-9297 [Print] United States
PMID11156536 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA
  • Phosphotransferases (Phosphomutases)
  • phosphomannomutase
Topics
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Base Sequence
  • Congenital Disorders of Glycosylation (enzymology, genetics, pathology)
  • DNA (chemistry, genetics)
  • DNA Mutational Analysis
  • Female
  • Fibroblasts (enzymology)
  • Gene Expression Regulation, Enzymologic
  • Genotype
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation
  • Phenotype
  • Phosphotransferases (Phosphomutases) (deficiency, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: